$250 | Single User
$500 | Site License
$750 | Global License

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Lowest Price Guaranteed: $250]

Published by Global Data: 08 Nov 2018 | 226725 | In Stock
Related Topics: Business , Drug , Drug Discovery , Equity , Financial , Healthcare , Pharmaceuticals

Introduction

Summary

Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. ADDF provides grants to the recipients for the treatment of Alzheimer’s disease. The foundation provides funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10

    Venture Financing 10

    M3 Biotechnology Raises USD15.2 Million in Venture Financing 10

    M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12

    Partnerships 13

    Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13

    Equity Offering 14

    Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14

    Alzheimer's Drug Discovery Foundation - Key Competitors 15

    Alzheimer's Drug Discovery Foundation - Key Employees 16

    Alzheimer's Drug Discovery Foundation - Locations And Subsidiaries 17

    Head Office 17

    Recent Developments 18

    Government and Public Interest 18

    May 10, 2018: .5 Million in New Funding Exemplifies ADDF's Strategy 18

    Apr 12, 2018: Inaugural Memories Matter Benefit Raises .2 Million for Alzheimers Drug Research 21

    Mar 28, 2018: Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2018 ADDF-Harrington Scholar Award 22

    Mar 13, 2018: Funding Supports New Approaches to Treat Multiple Types of Dementia 23

    Jan 09, 2018: Alzheimer’s Drug Discovery Foundation: .5 Million in New Grants Advance Clinical Trials of Alzheimers Treatments 24

    Jan 08, 2018: Alzheimer’s Drug Discovery Foundation: .8 Million in New Funding Supports Clinical Stage Treatments 25

    Jan 08, 2018: .8 Million in New Funding Supports Clinical Stage Treatments 27

    Nov 14, 2017: Alzheimer’s Drug Discovery Foundation Announces Three New Grants 29

    Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 30

    Sep 05, 2017: New Funding Supports Blood Test for Early Alzheimer’s 31

    May 15, 2017: .6 Million in New Grants Spurs Innovation 32

    Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 35

    Mar 07, 2017: Million in New Grants Support Several First-in-class Dementia Treatments 36

    Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 39

    Jan 09, 2017: .5 Million in New Grants Advance Clinical Trials of Alzheimer’s Treatments 40

    Product News 42

    Nov 01, 2017: New Report Highlights Innovation in Alzheimers Clinical Trials 42

    Jun 07, 2017: The Alzheimer's Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 43

    Other Significant Developments 44

    Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 44

    Appendix 45

    Methodology 45

    About GlobalData 45

    Contact Us 45

    Disclaimer 45

List Of Tables
in Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts, 2016 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2012 to YTD 2018 8

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

M3 Biotechnology Raises USD15.2 Million in Venture Financing 10

M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12

Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13

Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14

Alzheimer's Drug Discovery Foundation, Key Competitors 15

Alzheimer's Drug Discovery Foundation, Key Employees 16

List Of Figures, Charts and Diagrams
in Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

226725 | GDPH213658D

Number of Pages

45

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Alzheimers Drug Market Research Report Forecast 2017 to 2021
The Global Alzheimers Drug Market Research Report Forecast 2017-2021 is a valuable source of insight...
13 Nov 2017 by S&P Consulting USD $2,800 More Info
Global Alzheimers Drug Market Research Report Forecast 2017 to 2021
The Global Alzheimers Drug Market Research Report Forecast 2017-2021 is a valuable source of insight...
13 May 2017 by S&P Consulting USD $2,800 More Info

This report is published by Global Data

Download Free Report Summary PDF

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...